PPCB vs VMC · P/E 0.0, $3.9M cap vs P/E 35, rev $7.42B
Propanc Biopharma, Inc. Common Stock (PPCB) versus Vulcan Materials Company (VMC) — a side-by-side from cached financials, not a winner call.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Vulcan Materials Company (VMC) is a building materials company listed on NYSE.
PPCB does not have a complete income-statement cache yet.
Latest reported VMC revenue for 2024-12-31 was $7.42B. Net income was $913.1M. Revenue was down 4.7% from 2023-12-31 to 2024-12-31. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
PPCB currently screens at market cap $3.9M and trailing P/E 0.0. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
Not investment advice. Open the PPCB and VMC stock pages for the full models.
Not investment advice.